Agency Information Collection Activities: Submission for OMB Review; Comment Request, 74316-74317 [E7-25332]
Download as PDF
<![CDATA[
74316
Federal Register / Vol. 72, No. 249 / Monday, December 31, 2007 / Notices
performers in concert halls or radio
studios).
7. If the workplace identified to the
agency changes during the performance
of the grant, the grantee shall inform the
agency of the change(s), if it previously
identified the workplaces in question
(see paragraph five).
8. Definitions of terms in the
Nonprocurement Suspension and
Debarment common rule and Drug-Free
Workplace common rule apply to this
certification. Grantees’ attention is
called, in particular, to the following
definitions from these rules:
Controlled substance means a
controlled substance in Schedules I
through V of the Controlled Substances
Act (21 U.S.C. 812) and as further
defined by regulation (21 CFR 1308.11
through 1308.15);
Conviction means a finding of guilt
(including a plea of nolo contendere) or
imposition of sentence, or both, by any
judicial body charged with the
responsibility to determine violations of
the Federal or State criminal drug
statutes;
Criminal drug statute means a Federal
or non-Federal criminal statute
involving the manufacture, distribution,
dispensing, use, or possession of any
controlled substance;
Employee means the employee of a
grantee directly engaged in the
performance of work under a grant,
including: (i) All direct charge
employees; (ii) All indirect charge
employees unless their impact or
involvement is insignificant to the
performance of the grant; and, (iii)
Temporary personnel and consultants
who are directly engaged in the
performance of work under the grant
and who are on the grantee’s payroll.
This definition does not include
workers not on the payroll of the grantee
(e.g., volunteers, even if used to meet a
matching requirement; consultants or
independent contractors not on the
grantee’s payroll; or employees of
subrecipients or subcontractors in
covered workplaces).
sroberts on PROD1PC70 with NOTICES
Certification Regarding Drug-Free
Workplace Requirements
Alternate I. (Grantees Other Than
Individuals)
The grantee certifies that it will or
will continue to provide a drug-free
workplace by:
(a) Publishing a statement notifying
employees that the unlawful
manufacture, distribution, dispensing,
possession, or use of a controlled
substance is prohibited in the grantee’s
workplace and specifying the actions
that will be taken against employees for
violation of such prohibition;
VerDate Aug<31>2005
20:08 Dec 28, 2007
Jkt 214001
(b) Establishing an ongoing drug-free
awareness program to inform employees
about—
(1) The dangers of drug abuse in the
workplace;
(2) The grantee’s policy of
maintaining a drug-free workplace;
(3) Any available drug counseling,
rehabilitation, and employee assistance
programs; and
(4) The penalties that may be imposed
upon employees for drug abuse
violations occurring in the workplace;
(c) Making it a requirement that each
employee to be engaged in the
performance of the grant be given a copy
of the statement required by paragraph
(a);
(d) Notifying the employee in the
statement required by paragraph (a) that,
as a condition of employment under the
grant, the employee will—
(1) Abide by the terms of the
statement; and
(2) Notify the employer in writing of
his or her conviction for a violation of
a criminal drug statute occurring in the
workplace no later than five calendar
days after such conviction;
(e) Notifying the agency in writing
within 10 calendar days after receiving
notice under paragraph (d)(2) from an
employee or otherwise receiving actual
notice of such conviction. Employers of
convicted employees must provide
notice, including position title, to every
grant officer or other designee on whose
grant activity the convicted employee
was working, unless the Federal agency
has designated a central point for the
receipt of such notices. Notice shall
include the identification number(s) of
each affected grant;
(f) Taking one of the following
actions, within 30 calendar days of
receiving notice under paragraph (d)(2),
with respect to any employee who is so
convicted—
(1) Taking appropriate personnel
action against such an employee, up to
and including termination, consistent
with the requirements of the
Rehabilitation Act of 1973, as amended;
or
(2) Requiring such employee to
participate satisfactorily in a drug abuse
assistance or rehabilitation program
approved for such purposes by a
Federal, State, or local health, law
enforcement, or other appropriate
agency;
(g) Making a good faith effort to
continue to maintain a drug-free
workplace through implementation of
paragraphs (a), (b), (c), (d), (e) and (f).
(B) The grantee may insert in the
space provided below the site(s) for the
performance of work done in
connection with the specific grant:
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
Place of Performance (Street address,
city, county, state, zip code)
llllllllllllllllll
l
llllllllllllllllll
l
Check if there are workplaces on file
that are not identified here.
Alternate II. (Grantees Who Are
Individuals)
(a) The grantee certifies that, as a
condition of the grant, he or she will not
engage in the unlawful manufacture,
distribution, dispensing, possession, or
use of a controlled substance in
conducting any activity with the grant;
(b) If convicted of a criminal drug
offense resulting from a violation
occurring during the conduct of any
grant activity, he or she will report the
conviction, in writing, within 10
calendar days of the conviction, to every
grant officer or other designee, unless
the Federal agency designates a central
point for the receipt of such notices.
When notice is made to such a central
point, it shall include the identification
number(s) of each affected grant.
[FR Doc. E7–25341 Filed 12–28–07; 8:45 am]
BILLING CODE 4184–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Periodically, the Health Resources
and Services Administration (HRSA)
publishes abstracts of information
collection requests under review by the
Office of Management and Budget
(OMB), in compliance with the
Paperwork Reduction Act of 1995 (44
U.S.C. Chapter 35). To request a copy of
the clearance requests submitted to
OMB for review, call the HRSA Reports
Clearance Office on (301) 443–1129.
The following request has been
submitted to the Office of Management
and Budget for review under the
Paperwork Reduction Act of 1995:
Proposed Project: Ryan White HIV/
AIDS Treatment Modernization Act of
2006: Program Allocation and
Expenditure Forms (NEW)
The Ryan White HIV/AIDS Program
Allocation and Expenditure Reports will
enable the Health Resources and
Services Administration’s HIV/AIDS
Bureau to track spending requirements
for each program as outlined in the 2006
legislation. Grantees funded under Parts
A, B, C, and D of the Ryan White HIV/
E:\FR\FM\31DEN1.SGM
31DEN1
74317
Federal Register / Vol. 72, No. 249 / Monday, December 31, 2007 / Notices
AIDS Program (codified under Title
XXVI of the Public Health Service Act)
would be required to report financial
data to HRSA at the beginning and end
of their grant cycle.
All parts of the Ryan White HIV/AIDS
Program specify HRSA’s responsibilities
in the administration of grant funds.
Accurate allocation and expenditure
records of the grantees receiving Ryan
White HIV/AIDS Program funding are
critical to the implementation of the
legislation and thus are necessary for
HRSA to fulfill its responsibilities.
The new law changes how Ryan
White HIV/AIDS Program funds can be
used, with an emphasis on providing
life-saving and life-extending services
for people living with HIV/AIDS across
this country. More money will be spent
on direct health care for Ryan White
HIV/AIDS Program clients. Under the
new law, unless they receive a waiver,
grantees receiving funds under Parts A,
B, and C must spend at least 75 percent
of funds on ‘‘core medical services’’ and
can spend no more than 5 percent or 3
million dollars (whichever is smaller)
on clinical quality management. Under
Parts A–D, there is also a 10 percent
spending cap on grantee administration.
The forms would require grantees to
report on how funds are allocated and
spent on core and non-core services,
and on various program components,
such as administration, planning and
evaluation, and quality management.
The two forms are identical in the types
of information they collect. However,
the first report would track the
allocation of their award at the
Number of
grantee
respondents
Program under which grantee is funded
Part
Part
Part
Part
Part
Part
Responses
per grantee
beginning of their grant cycle and the
second report would track actual
expenditures (including carryover
dollars) at the end of their grant cycle.
The primary purposes of these forms
are to: (1) provide information on the
number of grant dollars spent on various
services and program components, and
(2) oversee compliance with the intent
of congressional appropriations in a
timely manner. In addition to meeting
the goal of accountability to the
Congress, clients, advocacy groups, and
the general public, information
collected on these reports is critical for
HRSA, State, and local grantees, and
individual providers to evaluate the
effectiveness of these programs.
The response burden for grantees is
estimated as:
Total
responses
Hours to
complete each
form
Total hours
A ...................................................................................
B ...................................................................................
A MAI ...........................................................................
B MAI ...........................................................................
C ...................................................................................
D ...................................................................................
56
59
56
59
361
90
2
2
2
2
2
2
112
118
112
118
722
180
8
12
4
4
7
7
896
1416
448
472
5054
1260
Total ..............................................................................
681
........................
1,362
........................
9,546
Written comments and
recommendations concerning the
proposed information collection should
be sent within 30 days of this notice to
the desk officer for HRSA, either by
email to
OIRA_submission@omb.eop.gov or by
fax to 202–395–6974. Please direct all
correspondence to the ‘‘attention of the
desk officer for HRSA.’’
Dated: December 20, 2007.
Alexandra Huttinger,
Acting Director, Division of Policy Review
and Coordination.
[FR Doc. E7–25332 Filed 12–28–07; 8:45 am]
collection requests under review by the
Office of Management and Budget
(OMB), in compliance with the
Paperwork Reduction Act of 1995 (44
U.S.C. Chapter 35). To request a copy of
the clearance requests submitted to
OMB for review, call the HRSA Reports
Clearance Office on (301) 443–1129.
The following request has been
submitted to the Office of Management
and Budget for review under the
Paperwork Reduction Act of 1995:
Proposed Project: HRSA AIDS Drug
Assistance Program Quarterly Report—
(OMB No. 0915–0295): Revision
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
sroberts on PROD1PC70 with NOTICES
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Periodically, the Health Resources
and Services Administration (HRSA)
publishes abstracts of information
VerDate Aug<31>2005
20:08 Dec 28, 2007
Jkt 214001
HRSA’s AIDS Drug Assistance
Program (ADAP) is funded through Part
B of Title XXVI of the Public Health
Service Act, as amended by the Ryan
White HIV/AIDS Treatment
Modernization Act of 2006 (The Ryan
White HIV/AIDS Program), which
provides grants to States and Territories.
The ADAP provides medications for the
treatment of HIV disease. Program funds
may also be used to purchase health
insurance for eligible clients or for
services that enhance access, adherence,
and monitoring of drug treatments.
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
Each of the 50 States, the District of
Columbia, Puerto Rico, and several
Territories receive ADAP grants. As part
of the funding requirements, ADAP
grantees submit quarterly reports that
include information on patients served,
pharmaceuticals prescribed, pricing,
and other sources of support to provide
AIDS medication treatment, eligibility
requirements, cost data, and
coordination with Medicaid. Each
quarterly report requests updates from
programs on number of patients served,
type of pharmaceuticals prescribed, and
prices paid to provide medication. The
first quarterly report of each ADAP
fiscal year (due in July of each year) also
requests information that only changes
annually (e.g., State funding, drug
formulary, eligibility criteria for
enrollment, and cost-saving strategies
including coordinating with Medicaid).
The quarterly report represents the
best method for HRSA to determine how
ADAP grants are being expended and to
provide answers to requests from
Congress and other organizations.
The estimated annual burden is as
follows:
E:\FR\FM\31DEN1.SGM
31DEN1
]]>Agencies
[Federal Register Volume 72, Number 249 (Monday, December 31, 2007)]
[Notices]
[Pages 74316-74317]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-25332]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Agency Information Collection Activities: Submission for OMB
Review; Comment Request
Periodically, the Health Resources and Services Administration
(HRSA) publishes abstracts of information collection requests under
review by the Office of Management and Budget (OMB), in compliance with
the Paperwork Reduction Act of 1995 (44 U.S.C. Chapter 35). To request
a copy of the clearance requests submitted to OMB for review, call the
HRSA Reports Clearance Office on (301) 443-1129.
The following request has been submitted to the Office of
Management and Budget for review under the Paperwork Reduction Act of
1995:
Proposed Project: Ryan White HIV/AIDS Treatment Modernization Act of
2006: Program Allocation and Expenditure Forms (NEW)
The Ryan White HIV/AIDS Program Allocation and Expenditure Reports
will enable the Health Resources and Services Administration's HIV/AIDS
Bureau to track spending requirements for each program as outlined in
the 2006 legislation. Grantees funded under Parts A, B, C, and D of the
Ryan White HIV/
[[Page 74317]]
AIDS Program (codified under Title XXVI of the Public Health Service
Act) would be required to report financial data to HRSA at the
beginning and end of their grant cycle.
All parts of the Ryan White HIV/AIDS Program specify HRSA's
responsibilities in the administration of grant funds. Accurate
allocation and expenditure records of the grantees receiving Ryan White
HIV/AIDS Program funding are critical to the implementation of the
legislation and thus are necessary for HRSA to fulfill its
responsibilities.
The new law changes how Ryan White HIV/AIDS Program funds can be
used, with an emphasis on providing life-saving and life-extending
services for people living with HIV/AIDS across this country. More
money will be spent on direct health care for Ryan White HIV/AIDS
Program clients. Under the new law, unless they receive a waiver,
grantees receiving funds under Parts A, B, and C must spend at least 75
percent of funds on ``core medical services'' and can spend no more
than 5 percent or 3 million dollars (whichever is smaller) on clinical
quality management. Under Parts A-D, there is also a 10 percent
spending cap on grantee administration.
The forms would require grantees to report on how funds are
allocated and spent on core and non-core services, and on various
program components, such as administration, planning and evaluation,
and quality management. The two forms are identical in the types of
information they collect. However, the first report would track the
allocation of their award at the beginning of their grant cycle and the
second report would track actual expenditures (including carryover
dollars) at the end of their grant cycle.
The primary purposes of these forms are to: (1) provide information
on the number of grant dollars spent on various services and program
components, and (2) oversee compliance with the intent of congressional
appropriations in a timely manner. In addition to meeting the goal of
accountability to the Congress, clients, advocacy groups, and the
general public, information collected on these reports is critical for
HRSA, State, and local grantees, and individual providers to evaluate
the effectiveness of these programs.
The response burden for grantees is estimated as:
----------------------------------------------------------------------------------------------------------------
Number of Hours to
Program under which grantee is grantee Responses per Total complete each Total hours
funded respondents grantee responses form
----------------------------------------------------------------------------------------------------------------
Part A.......................... 56 2 112 8 896
Part B.......................... 59 2 118 12 1416
Part A MAI...................... 56 2 112 4 448
Part B MAI...................... 59 2 118 4 472
Part C.......................... 361 2 722 7 5054
Part D.......................... 90 2 180 7 1260
-------------------------------------------------------------------------------
Total....................... 681 .............. 1,362 .............. 9,546
----------------------------------------------------------------------------------------------------------------
Written comments and recommendations concerning the proposed
information collection should be sent within 30 days of this notice to
the desk officer for HRSA, either by email to OIRA_
submission@omb.eop.gov or by fax to 202-395-6974. Please direct all
correspondence to the ``attention of the desk officer for HRSA.''
Dated: December 20, 2007.
Alexandra Huttinger,
Acting Director, Division of Policy Review and Coordination.
[FR Doc. E7-25332 Filed 12-28-07; 8:45 am]
BILLING CODE 4165-15-P
